NDC 72833-678-30 - Testosterone Cypionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72833-678
- Requested NDC
- 72833-678-30
- Package NDCs from labels
- 72833-678-30, 72833-678-00
- Manufacturer
- ASP Cares
- Effective date
- 2021-01-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Testosterone Cypionate - ASP Cares | ASP Cares | 2021-01-11 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72833-678-00 | 2023-01-30 | C162847 | 48780-1 | f386c649-e5f7-0266-e053-dadaa90a7c1a | 874dec5e-8910-3b3f-e053-2a95a90a8334 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72833-678-00 | Testosterone Cypionate | 1 in 1 BOX | INJECTION | 1 | 2 | |
| 72833-678-30 | Testosterone Cypionate | 30 mL in 1 VIAL, MULTI-DOSE | INJECTION | 30 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72833-678-30 | ML - Milliliter | 72833-678 | 1e623fa9-8cee-42cc-b47b-f6dbf23dcb89 | 1 | 2019-09-05 |
Compounder NDC reports#
| Establishment | FEI | Product NDC | Package NDC | Product | Active ingredients | Reporting period | Normalization |
|---|---|---|---|---|---|---|---|
| ASP Cares | 080070525 | 72833-678 | 72833-678-05 | Testosterone Cypionate | 200 mg/1 mL | 2021-1 | valid |
| ASP Cares | 080070525 | 72833-678 | 72833-678-05 | Testosterone Cypionate | 200 mg/1 mL | 2020-2 | valid |
| ASP Cares | 080070525 | 72833-678 | 72833-678-05 | Testosterone Cypionate | 200 mg/1 mL | 2020-1 | valid |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Asclemed USA, Inc. | 2f72be32-ede6-44d9-88a0-0653b53a3e47 | 2025-08-27 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hospira, Inc. | 6909596e-4bf7-4e11-8029-b89740a30aec | 2025-08-22 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NorthStar Rx LLC | 9ced69c7-cd37-efb6-1bf9-e21c01e56f5b | 2025-08-05 | Warnings, Adverse reactions | M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | Xiromed LLC | cab949ca-fde9-c5a9-5561-21e98d86d078 | 2025-08-05 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| AZMIRO | TESTOSTERONE CYPIONATE | Azurity Pharmaceuticals, Inc. | 235b5625-570d-3fba-e063-6394a90aa2d1 | 2025-07-25 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Wilshire Pharmaceuticals | 58ff6e0d-cc0a-4455-8254-d883d26a3b6d | 2025-07-24 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Pharmacia & Upjohn Company LLC | 735b5bf3-4464-412c-a072-1bd02f2e5380 | 2025-07-14 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | A-S Medication Solutions | e9d48af3-9514-4dc5-972c-0c1f2547e5c6 | 2025-07-09 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Cipla USA Inc. | b8ac5e07-b7e3-4a60-b0d1-8b1f3ad0c478 | 2025-06-30 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Padagis US LLC | 4195516a-c8e6-457c-b805-43c9a3ca8b77 | 2025-06-03 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Eugia US LLC | f901e2b2-f143-4237-8e95-0d134585490b | 2025-06-03 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hikma Pharmaceuticals USA Inc. | f60c5520-b336-44a2-95d5-f274939fa595 | 2025-06-01 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hikma Pharmaceuticals USA Inc. | 5ca67491-4b30-4a47-af0a-be250215d1f0 | 2025-06-01 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Sun Pharmaceutical Industries, Inc. | 3653a602-4551-4e6c-84a7-31861f5dc482 | 2025-05-30 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| TESTOSTERONE CYPIONATE | TESTOSTERONE CYPIONATE | Cipla USA Inc. | 78d55bad-4a5b-4e21-aeb8-a4c6346208be | 2025-05-09 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NuCare Pharmaceuticals, Inc. | 346604c7-22d0-60c5-e063-6394a90abf0b | 2025-05-05 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NuCare Pharmaceuticals,Inc. | 335ff614-15ec-0792-e063-6294a90a2f08 | 2025-04-22 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | NuCare pgarmaceuticals,Inc. | 30b453b9-25ef-8262-e063-6394a90a24c2 | 2025-03-19 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Arthcal VULVA BALM | BEESWAX,SHEA BUTTER,GRAPE SEED | Beijing JUNGE Technology Co., Ltd. | 2f305967-207b-6da9-e063-6294a90a571c | 2025-03-11 | Warnings | 930MLC8XGG |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.